Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4470387

O=C(O)C(F)(F)F.O=C(c1ccccc1)c1ccc(-c2c[nH]c(COc3ccccc3)n2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.41
GAA P10253 2/20 0.41
ALDH1A1 P00352 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
SRD5A2 P31213 2/20 0.40
PPARA Q07869 3/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
PPARD Q03181 1/20 0.38
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
LMNA P02545 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
AKR1B1 P15121 1/20 0.36
MAPK1 P28482 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685016 0.93 GAA (0.47) PPARGGAAALDH1A1HTTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL4460353 0.89 MCL1 (0.47) PPARGPPARAPPARDMCL1
SCHEMBL4681552 0.85 NR4A2 (0.49) SMN1; SMN2SRD5A2RAB9AMCL1
Trifluoroacetic Acid SCHEMBL4458367 0.84 MCL1 (0.48) PPARGSMN1; SMN2PPARARAB9APPARD
Trifluoroacetic Acid SCHEMBL4456741 0.83 MEN1 (0.57) SMN1; SMN2MAPTRAB9ALMNAKMT2A
Trifluoroacetic Acid SCHEMBL4470385 0.82 FFAR4 (0.36) PPARGPPARARAB9AMCL1
SCHEMBL4684167 0.81 MCL1 (0.50) SRD5A2MCL1
Trifluoroacetic Acid SCHEMBL8216241 0.80 HDAC3 (0.40) ALDH1A1HTTSMN1; SMN2PPARAMAPT
SCHEMBL5750527 0.79 LMNA (0.44) ALDH1A1SMN1; SMN2L3MBTL1MAPTRAB9A
SCHEMBL4466562 0.79 RAB9A (0.45) ALDH1A1SMN1; SMN2L3MBTL1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534805-B2 Imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-05-19 US claimed
EP-1638943-B1 NOVEL IMIDAZOLE DERIVATIVES, THE PRODUCTION THEREOF, AND THE USE OF THE SAME AS A MEDICAMENT SOD CONSEILS RECH APPLIC (FR) 2008-08-06 EP claimed
US-20070066542-A1 Novel imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.) (FR) 2007-03-22 US claimed
US-7534805-B2 Imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-05-19 US disclosed
US-20070066542-A1 Novel imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.) (FR) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066542-A1 Novel imidazole derivatives, their preparation and their use as medicaments MIF, MCL1, PPIP5K2 PPARG 1164/4885GAA 1255/4885ALDH1A1 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.